Clinical Insights: Alzheimer’s in Focus
Evidence, Answers and Perspectives Across an Evolving Alzheimer’s Landscape
Prime Therapeutics’ Clinical insights is your trusted resource for timely, evidence-based perspectives on emerging therapies and managed care strategy. Our Fall 2026 issue focuses on Alzheimer's disease — a neurodegenerative condition that affects more than 7.4 million Americans ages 65 and older.
Check out Clinical Insights: Alzheimer’s in Focus for a comprehensive look at advances in diagnosis and treatment, emerging research and what’s ahead.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.